+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Traumatic brain injuries assessment Market By End-User, By Diagnostic Type: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 250 Pages
  • January 2023
  • Region: Global
  • Allied Market Research
  • ID: 5751123
The global traumatic brain injuries assessment market size was $9,570 million in 2021 and is predicted to expand at a CAGR of 7.0% % by generating a revenue of $18,373.6 million by 2031.

Traumatic brain injuries assessment market growth is a significant public health issue in India. They contribute to the demise, harm, and disabling of young, active members of society. India suffers huge economic losses due to TBIs, yet they are unquantifiable. TBIs will rise in India as it moves toward greater growth and development in terms of motorization and urbanization. The World Health Organization's recent world reports on road traffic injury prevention and violence &health make clear how serious the problem of injuries is getting around the world and how urgently programs for prevention, management, and rehabilitation need to be designed and evaluated. India is one nation that has not prioritized prevention.

TBIs negatively affect executive function and self-control. The ability to control stress- and anxiety-related behavior is known as self-regulation. For someone with a TBI, this can involve difficulty settling down, difficulty waiting their turn, or having overpowering emotions in strange settings. Executive functioning refers to higher-order brain functions that are involved in planning, recalling, setting goals, focusing attention, and obeying directions. TBI sufferers may easily become disoriented or forget things, and they may find it challenging to learn new information, complete paperwork, or use public transportation.

The adoption of the most recent technologies and the launch of new products by market participants are expected to accelerate market expansion during the forecast period. For instance, Bio Direction, Inc.’s NanoDx system is a quick point-of-care (POC) diagnostic that accurately diagnoses concussions/TBIs in under two minutes.

The study, which is being funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), is still in progress, but preliminary findings indicate that the pandemic has a significant impact on those who have had brain injuries, including social isolation, disruption of daily life, and effects on cognition. The Administration for Community Living-funded Traumatic Brain Damage Technical Assistance and Resource Center (TBI TARC) set out to further study how COVID-19 has affected people with brain injuries. The TBI Advisory and Leadership (TAL) group's five members were questioned by the TBI TARC. The TAL group's goal is to direct TBI TARC's priorities.

The key players profiled in this report include Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the traumatic brain injuries assessment market analysis from 2021 to 2031 to identify the prevailing traumatic brain injuries assessment market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the traumatic brain injuries assessment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global traumatic brain injuries assessment market trends, key players, market segments, application areas, and market growth Strategies.

Key Market Segments

By End-user
  • Hospital
  • Diagnostics Center

By Diagnostic Type

  • CT-Scan
  • MRI
  • Intracranial Pressure Monitoring
  • Partial Pressure of Oxygen in Brain Tissue (pBrO2)

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of LAMEA

Key Market Players

  • brainscope company inc.
  • NOVASIGNAL CORPORATION
  • Integra LifeSciences Holdings Corporation
  • Natus Medical Incorporated
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • BioDirection, Inc.
  • Nihon Kohden Corp.
  • RAUMEDIC AG
  • Compumedics Ltd.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities
3.5.COVID-19 Impact Analysis on the market
3.6.Value Chain Analysis
3.7.Key Regulation Analysis
3.8.Patent Landscape
3.9.Regulatory Guidelines
3.10.Market Share Analysis
CHAPTER 4: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY END-USER
4.1 Overview
4.1.1 Market size and forecast
4.2. Hospital
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Diagnostics Center
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY DIAGNOSTIC TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2. CT-Scan
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. MRI
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4. Intracranial Pressure Monitoring
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
5.6. Others
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market share analysis by country
CHAPTER 6: TRAUMATIC BRAIN INJURIES ASSESSMENT MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by End-user
6.2.3 North America Market size and forecast, by Diagnostic Type
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by End-user
6.2.4.1.3 Market size and forecast, by Diagnostic Type
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by End-user
6.2.4.2.3 Market size and forecast, by Diagnostic Type
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by End-user
6.2.4.3.3 Market size and forecast, by Diagnostic Type
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by End-user
6.3.3 Europe Market size and forecast, by Diagnostic Type
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by End-user
6.3.4.1.3 Market size and forecast, by Diagnostic Type
6.3.4.2 UK
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by End-user
6.3.4.2.3 Market size and forecast, by Diagnostic Type
6.3.4.3 France
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by End-user
6.3.4.3.3 Market size and forecast, by Diagnostic Type
6.3.4.4 Spain
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by End-user
6.3.4.4.3 Market size and forecast, by Diagnostic Type
6.3.4.5 Italy
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by End-user
6.3.4.5.3 Market size and forecast, by Diagnostic Type
6.3.4.6 Rest of Europe
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by End-user
6.3.4.6.3 Market size and forecast, by Diagnostic Type
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by End-user
6.4.3 Asia-Pacific Market size and forecast, by Diagnostic Type
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by End-user
6.4.4.1.3 Market size and forecast, by Diagnostic Type
6.4.4.2 Japan
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by End-user
6.4.4.2.3 Market size and forecast, by Diagnostic Type
6.4.4.3 India
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by End-user
6.4.4.3.3 Market size and forecast, by Diagnostic Type
6.4.4.4 South Korea
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by End-user
6.4.4.4.3 Market size and forecast, by Diagnostic Type
6.4.4.5 Australia
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by End-user
6.4.4.5.3 Market size and forecast, by Diagnostic Type
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by End-user
6.4.4.6.3 Market size and forecast, by Diagnostic Type
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by End-user
6.5.3 LAMEA Market size and forecast, by Diagnostic Type
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by End-user
6.5.4.1.3 Market size and forecast, by Diagnostic Type
6.5.4.2 Saudi Arabia
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by End-user
6.5.4.2.3 Market size and forecast, by Diagnostic Type
6.5.4.3 UAE
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by End-user
6.5.4.3.3 Market size and forecast, by Diagnostic Type
6.5.4.4 South Africa
6.5.4.4.1 Key market trends, growth factors and opportunities
6.5.4.4.2 Market size and forecast, by End-user
6.5.4.4.3 Market size and forecast, by Diagnostic Type
6.5.4.5 Rest of LAMEA
6.5.4.5.1 Key market trends, growth factors and opportunities
6.5.4.5.2 Market size and forecast, by End-user
6.5.4.5.3 Market size and forecast, by Diagnostic Type
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1 brainscope company inc.
8.1.1 Company overview
8.1.2 Key Executives
8.1.3 Company snapshot
8.1.4 Operating business segments
8.1.5 Product portfolio
8.1.6 Business performance
8.1.7 Key strategic moves and developments
8.2 NOVASIGNAL CORPORATION
8.2.1 Company overview
8.2.2 Key Executives
8.2.3 Company snapshot
8.2.4 Operating business segments
8.2.5 Product portfolio
8.2.6 Business performance
8.2.7 Key strategic moves and developments
8.3 Integra LifeSciences Holdings Corporation
8.3.1 Company overview
8.3.2 Key Executives
8.3.3 Company snapshot
8.3.4 Operating business segments
8.3.5 Product portfolio
8.3.6 Business performance
8.3.7 Key strategic moves and developments
8.4 Natus Medical Incorporated
8.4.1 Company overview
8.4.2 Key Executives
8.4.3 Company snapshot
8.4.4 Operating business segments
8.4.5 Product portfolio
8.4.6 Business performance
8.4.7 Key strategic moves and developments
8.5 Boston Scientific Corporation
8.5.1 Company overview
8.5.2 Key Executives
8.5.3 Company snapshot
8.5.4 Operating business segments
8.5.5 Product portfolio
8.5.6 Business performance
8.5.7 Key strategic moves and developments
8.6 Koninklijke Philips N.V.
8.6.1 Company overview
8.6.2 Key Executives
8.6.3 Company snapshot
8.6.4 Operating business segments
8.6.5 Product portfolio
8.6.6 Business performance
8.6.7 Key strategic moves and developments
8.7 BioDirection, Inc.
8.7.1 Company overview
8.7.2 Key Executives
8.7.3 Company snapshot
8.7.4 Operating business segments
8.7.5 Product portfolio
8.7.6 Business performance
8.7.7 Key strategic moves and developments
8.8 Nihon Kohden Corp.
8.8.1 Company overview
8.8.2 Key Executives
8.8.3 Company snapshot
8.8.4 Operating business segments
8.8.5 Product portfolio
8.8.6 Business performance
8.8.7 Key strategic moves and developments
8.9 RAUMEDIC AG
8.9.1 Company overview
8.9.2 Key Executives
8.9.3 Company snapshot
8.9.4 Operating business segments
8.9.5 Product portfolio
8.9.6 Business performance
8.9.7 Key strategic moves and developments
8.10 Compumedics Ltd.
8.10.1 Company overview
8.10.2 Key Executives
8.10.3 Company snapshot
8.10.4 Operating business segments
8.10.5 Product portfolio
8.10.6 Business performance
8.10.7 Key strategic moves and developments
List of Tables
Table 1. Global Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 2. Traumatic Brain Injuries Assessment Market for Hospital, by Region, 2021-2031 (Revenue, $Million)
Table 3. Traumatic Brain Injuries Assessment Market for Diagnostics Center, by Region, 2021-2031 (Revenue, $Million)
Table 4. Traumatic Brain Injuries Assessment Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 5. Global Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 6. Traumatic Brain Injuries Assessment Market for CT-Scan, by Region, 2021-2031 (Revenue, $Million)
Table 7. Traumatic Brain Injuries Assessment Market for MRI, by Region, 2021-2031 (Revenue, $Million)
Table 8. Traumatic Brain Injuries Assessment Market for Intracranial Pressure Monitoring, by Region, 2021-2031 (Revenue, $Million)
Table 9. Traumatic Brain Injuries Assessment Market for Partial Pressure of Oxygen in Brain Tissue (Pbro2), by Region, 2021-2031 (Revenue, $Million)
Table 10. Traumatic Brain Injuries Assessment Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 11. Traumatic Brain Injuries Assessment Market, by Region, 2021-2031 (Revenue, $Million)
Table 12. North America Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 13. North America Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 14. North America Traumatic Brain Injuries Assessment Market, by Country, 2021-2031 (Revenue, $Million)
Table 15. U.S. Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 16. U.S. Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 17. Canada Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 18. Canada Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 19. Mexico Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 20. Mexico Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 21. Europe Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 22. Europe Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 23. Europe Traumatic Brain Injuries Assessment Market, by Country, 2021-2031 (Revenue, $Million)
Table 24. Germany Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 25. Germany Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 26. UK Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 27. UK Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 28. France Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 29. France Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 30. Spain Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 31. Spain Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 32. Italy Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 33. Italy Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 34. Rest of Europe Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 35. Rest of Europe Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 36. Asia-Pacific Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 37. Asia-Pacific Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 38. Asia-Pacific Traumatic Brain Injuries Assessment Market, by Country, 2021-2031 (Revenue, $Million)
Table 39. China Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 40. China Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 41. Japan Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 42. Japan Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 43. India Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 44. India Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 45. South Korea Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 46. South Korea Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 47. Australia Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 48. Australia Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 49. Rest of Asia-Pacific Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 50. Rest of Asia-Pacific Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 51. LAMEA Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 52. LAMEA Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 53. LAMEA Traumatic Brain Injuries Assessment Market, by Country, 2021-2031 (Revenue, $Million)
Table 54. Brazil Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 55. Brazil Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 56. Saudi Arabia Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 57. Saudi Arabia Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 58. UAE Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 59. UAE Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 60. South Africa Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 61. South Africa Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 62. Rest of LAMEA Traumatic Brain Injuries Assessment Market, by End-user, 2021-2031 (Revenue, $Million)
Table 63. Rest of LAMEA Traumatic Brain Injuries Assessment Market, by Diagnostic Type, 2021-2031 (Revenue, $Million)
Table 64. Brainscope Company Inc.: Key Executives
Table 65. Brainscope Company Inc.: Company Snapshot
Table 66. Brainscope Company Inc.: Operating Segments
Table 67. Brainscope Company Inc.: Product Portfolio
Table 68. Brainscope Company Inc.: Net Sales
Table 69. Brainscope Company Inc.: Key Strategies
Table 70. Novasignal Corporation: Key Executives
Table 71. Novasignal Corporation: Company Snapshot
Table 72. Novasignal Corporation: Operating Segments
Table 73. Novasignal Corporation: Product Portfolio
Table 74. Novasignal Corporation: Net Sales
Table 75. Novasignal Corporation: Key Strategies
Table 76. Integra Lifesciences Holdings Corporation: Key Executives
Table 77. Integra Lifesciences Holdings Corporation: Company Snapshot
Table 78. Integra Lifesciences Holdings Corporation: Operating Segments
Table 79. Integra Lifesciences Holdings Corporation: Product Portfolio
Table 80. Integra Lifesciences Holdings Corporation: Net Sales
Table 81. Integra Lifesciences Holdings Corporation: Key Strategies
Table 82. Natus Medical Incorporated: Key Executives
Table 83. Natus Medical Incorporated: Company Snapshot
Table 84. Natus Medical Incorporated: Operating Segments
Table 85. Natus Medical Incorporated: Product Portfolio
Table 86. Natus Medical Incorporated: Net Sales
Table 87. Natus Medical Incorporated: Key Strategies
Table 88. Boston Scientific Corporation: Key Executives
Table 89. Boston Scientific Corporation: Company Snapshot
Table 90. Boston Scientific Corporation: Operating Segments
Table 91. Boston Scientific Corporation: Product Portfolio
Table 92. Boston Scientific Corporation: Net Sales
Table 93. Boston Scientific Corporation: Key Strategies
Table 94. Koninklijke Philips N.V.: Key Executives
Table 95. Koninklijke Philips N.V.: Company Snapshot
Table 96. Koninklijke Philips N.V.: Operating Segments
Table 97. Koninklijke Philips N.V.: Product Portfolio
Table 98. Koninklijke Philips N.V.: Net Sales
Table 99. Koninklijke Philips N.V.: Key Strategies
Table 100. Biodirection, Inc.: Key Executives
Table 101. Biodirection, Inc.: Company Snapshot
Table 102. Biodirection, Inc.: Operating Segments
Table 103. Biodirection, Inc.: Product Portfolio
Table 104. Biodirection, Inc.: Net Sales
Table 105. Biodirection, Inc.: Key Strategies
Table 106. Nihon Kohden Corp.: Key Executives
Table 107. Nihon Kohden Corp.: Company Snapshot
Table 108. Nihon Kohden Corp.: Operating Segments
Table 109. Nihon Kohden Corp.: Product Portfolio
Table 110. Nihon Kohden Corp.: Net Sales
Table 111. Nihon Kohden Corp.: Key Strategies
Table 112. Raumedic AG: Key Executives
Table 113. Raumedic AG: Company Snapshot
Table 114. Raumedic AG: Operating Segments
Table 115. Raumedic AG: Product Portfolio
Table 116. Raumedic AG: Net Sales
Table 117. Raumedic AG: Key Strategies
Table 118. Compumedics Ltd.: Key Executives
Table 119. Compumedics Ltd.: Company Snapshot
Table 120. Compumedics Ltd.: Operating Segments
Table 121. Compumedics Ltd.: Product Portfolio
Table 122. Compumedics Ltd.: Net Sales
Table 123. Compumedics Ltd.: Key Strategies
List of Figures
Figure 1. Segmentation of Traumatic Brain Injuries Assessment Market,2021-2031
Figure 2. Traumatic Brain Injuries Assessment Market,2021-2031
Figure 3. Top Investment Pockets, by Region
Figure 4. Porter Five-1
Figure 5. Porter Five-2
Figure 6. Porter Five-3
Figure 7. Porter Five-4
Figure 8. Porter Five-5
Figure 9. Traumatic Brain Injuries Assessment Market:Drivers, Restraints and Opportunities
Figure 10. Value Chain Analysis
Figure 11. Key Regulation Analysis
Figure 12. Patent Analysis by Company
Figure 13. Patent Analysis by Country
Figure 14. Regulatory Guidelines
Figure 15. Market Share Analysis
Figure 16. Traumatic Brain Injuries Assessment Market,By End-user,2021(%)
Figure 17. Comparative Share Analysis of Hospital Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 18. Comparative Share Analysis of Diagnostics Center Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 19. Comparative Share Analysis of Others Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 20. Traumatic Brain Injuries Assessment Market,By Diagnostic Type,2021(%)
Figure 21. Comparative Share Analysis of CT-Scan Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 22. Comparative Share Analysis of MRI Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 23. Comparative Share Analysis of Intracranial Pressure Monitoring Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 24. Comparative Share Analysis of Partial Pressure of Oxygen in Brain Tissue (Pbro2) Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 25. Comparative Share Analysis of Others Traumatic Brain Injuries Assessment Market, 2021 and 2031(%)
Figure 26. Traumatic Brain Injuries Assessment Market by Region,2021
Figure 27. U.S. Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 28. Canada Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 29. Mexico Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 30. Germany Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 31. UK Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 32. France Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 33. Spain Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 34. Italy Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 35. Rest of Europe Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 36. China Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 37. Japan Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 38. India Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 39. South Korea Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 40. Australia Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 41. Rest of Asia-Pacific Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 42. Brazil Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 43. Saudi Arabia Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 44. UAE Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 45. South Africa Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 46. Rest of LAMEA Traumatic Brain Injuries Assessment Market,2021-2031($Million)
Figure 47. Top Winning Strategies, by Year
Figure 48. Top Winning Strategies, by Development
Figure 49. Top Winning Strategies, by Company
Figure 50. Product Mapping of Top 10 Players
Figure 51. Competitive Dashboard
Figure 52. Competitive Heatmap of Top 10 Key Players
Figure 53. Top Player Positioning, 2021
Figure 54. Brainscope Company Inc..: Net Sales ($Million)
Figure 55. Novasignal Corporation.: Net Sales ($Million)
Figure 56. Integra Lifesciences Holdings Corporation.: Net Sales ($Million)
Figure 57. Natus Medical Incorporated.: Net Sales ($Million)
Figure 58. Boston Scientific Corporation.: Net Sales ($Million)
Figure 59. Koninklijke Philips N.V..: Net Sales ($Million)
Figure 60. Biodirection, Inc..: Net Sales ($Million)
Figure 61. Nihon Kohden Corp..: Net Sales ($Million)
Figure 62. Raumedic AG.: Net Sales ($Million)
Figure 63. Compumedics Ltd..: Net Sales ($Million)

Executive Summary

According to the report titled, 'Traumatic brain injuries assessment Market,' the traumatic brain injuries assessment market was valued at $9.6 billion in 2021, and is estimated to reach $18.4 billion by 2031, growing at a CAGR of 7% from 2022 to 2031.

Traumatic brain injury is defined as ''a change in brain function, or other signs of brain pathology, produced by an external force.’’ It happens when an outside force strikes the brain and is frequently brought on by a blow, bump, jolt, or piercing head wound. However, not all strikes or jolts to the head result in traumatic brain injury; some only harm the skull's bony structure without harming the brain.

Rising cases of traumatic brain injuries among people, globally, owing to various factors like brain injury, accident, trauma, depression, and stress is expected to drive the market of traumatic brain injuries assessment market in the coming years. The number of drugs being developed for the treatment of traumatic brain injury (TBI) is increasing significantly as a result of the condition's increased incidence. Many drugs in the clinical trials of development are expected to receive marketing approval within the forecast period. Traumatic brain injuries are an important public health concern that cause a sizeable number of cases each year all over the world. For instance, approximately 3.5 million Americans currently suffer from a persistent handicap brought on by a traumatic brain injury, according to the CDC. Most of these cases are a result of accidents. As a result, it is anticipated that rising numbers of traffic accidents and injuries will increase the need for TBI assessment and management tools.

The market also offers growth opportunities to the key players in the market. An increase in patients' preferences for minimally invasive neurosurgeries is anticipated to fuel traumatic brain injuries assessment market expansion. Currently, minimally invasive techniques can be used to treat the majority of TBIs, including MRI or CT scans, transcranial Doppler ultrasound, and endoscopy to remove hematomas or contusions that developed after brain injury. With the aid of such sophisticated tools, neurosurgeons can access deep brain lesions through a pinhole-sized hole in the skull without endangering the nearby tissues.

The traumatic brain injuries assessment market is segmented into end-user, diagnostic type, and region. On the basis of end-user, the hospital and diagnostic center. On the basis of diagnostic type, the market is categorized into CT-Scan, MRI, intracranial pressure monitoring, partial pressure of oxygen in brain tissue (pBrO2), and others. Region wise, the market was analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, Italy, France, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA.

The key players profiled in the study include Integra Lifesciences, Bio Direction, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta. On September 2, 2022, Tri-anim Health Services, specialty distributor of respiratory devices, announced that it has established an exclusive partnership to promote and provide the BrainScope device to hospital emergency departments.

Key Market Insights

By end use, the hospitalized segment was the highest revenue contributor to the market. The main causes of the expansion were an increase in inpatient brain surgeries and a rise in the number of TBI patients globally. Furthermore, hospitals have state-of-the-art equipment that is used by skilled neurologists, which is expected to hasten the segment's growth over the projection period.

By diagnostic type, the CT scan segment dominated the global market in 2021. The growth of the sub segment is attributed to the high preference of CT scan among healthcare professionals to understand the prevalence of brain disorder in patients.

Based on region, North America was the highest revenue contributor in 2021. The major reason for the fastest growth is due to growing incidences of brain injuries among people due to high cases of accidents.

Companies Mentioned

  • brainscope company inc.
  • NOVASIGNAL CORPORATION
  • Integra LifeSciences Holdings Corporation
  • Natus Medical Incorporated
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • BioDirection, Inc.
  • Nihon Kohden Corp.
  • RAUMEDIC AG
  • Compumedics Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...